3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
31
Polycystic Ovary Syndrome
9
Breast Neoplasms
8
Infertility
7
Ovarian Hyperstimulation Syndrome
3
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Prostate Adenocarcinoma
2
Osteosarcoma
2
Neoplasms
2
Uterine Anomalies
1
The Neoadjuvant Therapy
1
Salpingitis
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Neoplasm Metastasis
1
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
1
Myofibroma
1
Metabolic Syndrome
1
Leiomyoma
1
Infertility, Female
1
Hypogonadism
1
Hodgkin Disease
1
Helping Behavior
1
Fatty Liver
1
Endometritis
1
Endometriosis
1
Drug-Related Side Effects and Adverse Reactions
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Interventions
Blood Specimen Collection
2
cetrorelix
1
Triptorelin Pamoate
1
Thioctic Acid
1
Positron-Emission Tomography
1
Pentoxifylline
1
Menotropins
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Goserelin
1
Gonadotropins
1
Genetic Testing
1
Clomiphene
1
Chorionic Gonadotropin
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Primary Ovarian Insufficiency
×
Triptorelin Pamoate
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled